Y
Yolonda L. Colson
Researcher at Harvard University
Publications - 208
Citations - 9193
Yolonda L. Colson is an academic researcher from Harvard University. The author has contributed to research in topics: Lung cancer & Medicine. The author has an hindex of 47, co-authored 186 publications receiving 7751 citations. Previous affiliations of Yolonda L. Colson include Brigham and Women's Hospital & University of Pittsburgh.
Papers
More filters
Journal ArticleDOI
Local Drug Delivery Strategies for Cancer Treatment: Gels, Nanoparticles, Polymeric Films, Rods, and Wafers
TL;DR: The aims of this article are to review the most well-studied and efficacious local polymer delivery systems from the last two decades, to examine the rationale for utilizing drug-eluting polymer implants in cancer patients, and to identify the patient cohorts that could most benefit from localized therapy.
Journal ArticleDOI
Polymer–drug conjugate therapeutics: advances, insights and prospects
TL;DR: The rational design, physicochemical characteristics and recent advances in the development of different classes of polymer–drug conjugates, including polymer–protein and polymer–small-molecule drug conjugating, dendrimers, polymer nanoparticles and multifunctional systems are discussed.
Journal ArticleDOI
Prevention, Early Detection, and Management of Complications After 328 Consecutive Extrapleural Pneumonectomies
David J. Sugarbaker,Michael T. Jaklitsch,Raphael Bueno,William G. Richards,Jeanne M. Lukanich,Steven J. Mentzer,Yolonda L. Colson,Phillip Linden,Michael Chang,Leah Capalbo,Elizabeth Oldread,Siyamek Neragi-Miandoab,Scott J. Swanson,Lambros Zellos +13 more
TL;DR: Complications after extrapleural pneumonectomy require a unique approach to management, and mortality can be minimized by early detection and aggressive treatment.
Journal ArticleDOI
Superhydrophobic materials for biomedical applications.
TL;DR: The review begins with a discussion of superhydrophobicity, and then explores biomedical applications that are utilizingsuperhydrophobic biomaterials for medical applications in depth including material selection characteristics, in vitro performance, and in vivo performance.
Journal ArticleDOI
Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database.
Carlos M. Mery,Anastasia N. Pappas,Raphael Bueno,Yolonda L. Colson,Philip A. Linden,David J. Sugarbaker,Michael T. Jaklitsch +6 more
TL;DR: Age is an independent predictor of postsurgical survival in NSCLC patients, even after adjustment for significant covariates, and among younger patients undergoing curative surgery, lobectomies are more commonly performed and confer a significant survival benefit over limited resections.